ArticleNature communications2026
Public institutions for cleantech commercialization in the United States.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The United States has been building public institutions to promote cleantech commercialization since the 1970s oil crisis. The ascent of new industrial policy has accelerated this process substantially since 2020, resulting in a doubling of the total number of institutions by 2024. Introducing a dataset of 122 institutions, we show how institutions perform five functions: goal setting, coordination, derisking, imposing discipline, and external engagement. Further, we demonstrate how post-2020 institutions extend and diverge from historical trends, highlighting the recent buildout of planning capacity, the widespread use of conditionalities, and the pivot toward engagement with local and non-firm actors. We conclude with an analysis of how the second Trump administration is transforming the cleantech commercialization system through retrenching, redesigning, repurposing, and maintaining institutions. We offer a bottom-up, institution-level examination of the emergence and evolution of state capacity for green industrial policy in the United States, its functions, and current developments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.